8-K
filed April 30, 2026, 7:59 PM ET
ticker CAH
CIK 0000721371
earnings
confidence high
sentiment positive
materiality 0.80
Cardinal Health Q3 revenue +11% to $60.9B, non-GAAP EPS $3.17 (+35%), raises FY26 outlook
CARDINAL HEALTH INC
- Non-GAAP EPS $3.17, up 35% YoY; GAAP EPS $1.69, down 20% on $184M goodwill impairment in Navista & ION.
- Revenue $60.9B, +11%; Pharmaceutical & Specialty segment profit +18% to $784M.
- FY26 non-GAAP EPS guidance raised to $10.70-$10.80; adjusted free cash flow raised to $3.3B-$3.7B.
- Global Medical segment profit fell 36% to $25M due to tariff impact; Other segment profit up 34% to $179M.
- Completed $250M accelerated share repurchase; YTD buybacks $1.0B; leverage ratio lowered to 3.0X.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
CARDINAL HEALTH INC reported FY26 results: EPS $10.70 to $10.80. Guidance raised.
- Period
- FY26
- EPS
- $10.70 to $10.80
- Guidance
- raised
- Result
- guidance update
Exact text from the filing
Cardinal Health is raising and narrowing its fiscal year 2026 guidance for non-GAAP diluted EPS attributable to Cardinal Health, Inc. to a range of $10.70 to $10.80 (+30% to +31% growth).
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
CARDINAL HEALTH INC reported Q3 FY26 results: revenue $60.9 billion, net income $750 million, EPS $3.17.
- Period
- Q3 FY26
- Revenue
- $60.9 billion
- Net income
- $750 million
- EPS
- $3.17
- Result
- reported results
Exact text from the filing
Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2026 revenues of $60.9 billion, an increase of 11% from the third quarter of fiscal year 2025. Third quarter GAAP operating earnings decreased 30% to $509 million and GAAP diluted earnings per share (EPS) decreased 20% to $1.69
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
CARDINAL HEALTH INC reported Q3 FY26 results: revenue $60.9 billion, net income $750 million, EPS $3.17.
- Period
- Q3 FY26
- Revenue
- $60.9 billion
- Net income
- $750 million
- EPS
- $3.17
- Result
- reported results
Exact text from the filing
to this report. --- EX-99.1 (EX-99.1) --- FOR IMMEDIATE RELEASE Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook • Revenue increased 11% to $60.9 billion • GAAP 1 operating earnings decreased 30% to $509 million; GAAP diluted EPS decreased 20% to $1.69 • Non-GAAP operating earnings increased 18% to $956 million; non-GAAP diluted
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.